Investigating Neurocognitive Disorders Epidemiology
Conditions: Dementia; Cognitive Decline; Alzheimer Disease Interventions: Diagnostic Test: Plasma tau phosphorylated at Thr217; Other: Neurocognitive examination Sponsors: King Chulalongkorn Memorial Hospital; Health Systems Research Institute,Thailand Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
A Prospective Study of Whole-Brain RT Combined With Thiotepa Sheath Injection Combined With Systemic Therapy for the Primary Disease in the Treatment of Meningeal Metastases in Solid Tumors
Conditions: Solid Tumor Leptomeningeal Metastasis Interventions: Drug: Intrathecal Injection of Thiotepa+Radiation+Systemic Treatment of Primary Diseases Sponsors: Second Affiliated Hospital, School of Medicine, Zhejiang University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
Digital Sleep Optimization for Brain Health Outcomes in Older Surgical Patients
Conditions: Insomnia; Postoperative Delirium; Delayed Neurocognitive Recovery; Postoperative Neurocognitive Disorder Interventions: Behavioral: digital Cognitive Behavioral Therapy for Insomnia (dCBT-I); Behavioral: Sleep Health Education Sponsors: Massachusetts General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
Pilot and Feasibility of MEMI for Chronic Traumatic Brain Injury
Conditions: Traumatic Brain Injury Interventions: Behavioral: MEMI (Memory Ecological Momentary Intervention) Spaced Retrieval; Behavioral: Blocked Retrieval Sponsors: Vanderbilt University Medical Center Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
M3-JIA: Making Mindfulness Matter for Children With JIA
Conditions: Juvenile Idiopathic Arthritis; Children; Mental Health; Mental Well-being Interventions: Behavioral: M3 Intervention group; Behavioral: M3 Waitlist Group Sponsors: Lawson Health Research Institute; Brain Canada Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
Task Atlas: Study to Develop a Task Atlas of Brain Recruitment During a Digital Game-based Program
Conditions: Healthy Adults Sponsors: Lumos Labs, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
Nilatinib Maleate Tablets Combined With Capecitabine in the Treatment of HER2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastases
Conditions: Her2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastasis Interventions: Drug: Neratinib maleate in combination with capecitabine Sponsors: Convalife (Shanghai) Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
Vertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain
BOSTON--(BUSINESS WIRE)--Apr. 18, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced important advancements across its suzetrigine pain program, which has the potential to be the first new class of medicine for acute and... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 18, 2024 Category: Pharmaceuticals Source Type: clinical trials
Placenta Derived Stem Cells for Treating of Chronic Ulcers and Neuropathy
Conditions: Diabetic Foot; Diabetic Neuropathies; Diabetic Foot Ulcer Interventions: Biological: Transplantation of Placenta Derived Stem Cells Sponsors: Michael H Carstens; Ministerio de Salud de Nicaragua; Wake Forest Institute for Regenerative Medicine Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Early Immunotherapy With Intravenous Immunoglobulin, Cyclophosphamide and Methylprednisolone in Patients With Anti-Hu-associated Paraneoplastic Sensory Neuronopathy
Conditions: Paraneoplastic Sensory Neuronopathy Interventions: Drug: Immunoglobulins IV (CLAYRIG); Drug: Cyclophosphamide IV; Drug: Methylprednisolone IV Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Acceptability and Safety of MR-C-014 in Persons With Neuromyelitis Optica Spectrum Disorder
Conditions: Neuromyelitis Optica Spectrum Disorder Interventions: Device: MR-C-014 Sponsors: MedRhythms, Inc.; Alexion Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Interventional Neuromodulation in Fibromyalgia
Conditions: Neuromodulation and Sleep Disorders Interventions: Device: repetitive transcranial magnetic stimulation active stimulation; Device: repetitive transcranial magnetic stimulation sham stimulation Sponsors: Tanta University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma.
Conditions: Neuroendocrine Carcinoma Interventions: Biological: ZG005; Drug: Etoposide; Drug: Cisplatin; Drug: Placebo Sponsors: Suzhou Zelgen Biopharmaceuticals Co.,Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
A Novel Use of a Sleep Intervention to Target the Emotion Regulation Brain Network to Treat Depression and Anxiety (R33 Phase)
Conditions: Insomnia; Depression Interventions: Behavioral: Cognitive Behavioral Therapy for Insomnia Sponsors: Stanford University; National Institute of Mental Health (NIMH) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Investigating the Plasticity of Human Predictive Coding Through Neuromodulation
Conditions: Human Brain and Cognition Interventions: Procedure: Occipital tACS at IAF-2Hz; Procedure: Occipital tACS at IAF+2Hz; Procedure: Frontal tACS at 4-7 Hz; Procedure: Occipital tRNS; Procedure: Frontal tRNS; Procedure: Sham/placebo tACS; Procedure: Sham/placebo tRNS Sponsors: Universit à Vita-Salute San Raffaele; Alessia Santoni; Sara Stottmeier; Klara Hemmerich; Giuseppe Di Dona; Luigi Ferini-Strambi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
